Bio/Pharma News

Merck Acquires Cubist Pharmaceuticals

December 08, 2014

The acquisition will enhance Merck's "superbug" medication portfolio.

Sandoz's Biosimilar Shows Similarity to Amgen's Neupogen

December 08, 2014

Sandoz announces their version of filgrastim, a follow-on biologic for the treatment of neutropenia, is as safe and effective as Amgen's Neupogen.

FTC Announces Conditions on GSK and Novartis Joint Venture Agreement

December 02, 2014

The US Federal Trade Commission will require Novartis AG to divest its nicotine replacement therapy patch business to continue the joint venture with GlaxoSmithKline.

Dalton Receives Funding for Development of RSV and Parainfluenza Type 3 Vaccines

December 01, 2014

Dalton Pharma Services announced it was awarded funding from ISTPCanada for its project to develop vaccines for respiratory syncytial virus and parainfluenza type 3.

MGB Biopharma Shortlisted for Scottish Enterprise Life Sciences Award

December 01, 2014

The company's lead candidate, MGB-BP-3, has shown promising results against a broad range of multi-resistant Gram-positive strains.

AbbVie Acquires API Manufacturing Facility In Singapore

November 25, 2014

The Singapore API facility will be operational by 2016.

AstraZeneca Expands Biologics Manufacturing in Maryland

November 25, 2014

The more than $200 million project will increase production capacity at the facility to support AstraZeneca':s maturing pipeline.

GSK Leads Big Pharma in Making Its Medicines Accessible

November 24, 2014

An index from the Access to Medicine Foundation ranks GSK as most effective in making products accessible.

Lundbeck CEO Resigns Due to Code of Conduct Breach

November 24, 2014

Ulf Wiinberg has resigned as Lundbeck's CEO over unapproved acceptance of shares in a biotech company.

GSK Announces Shareholders Meeting to Discuss Novartis Deal

November 24, 2014

GSK and Novartis announced a meeting on Dec. 18, 2014 to discuss the $20 billion asset swap between the two companies.